Skip to main content

Kiniksa Pharmaceuticals International, plc

KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001730430

In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Kiniksa Pharmaceuticals International, plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
2 insiders, $668.5K in total
Insiders trading
2
Net value
−$668.5K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Kiniksa Pharmaceuticals International, plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Kiniksa Pharmaceuticals International, plc
NameTitleLast reported holdingLast filingFilings, past year
Ragosa MarkCHIEF FINANCIAL OFFICER20,854Sep 3, 20269
Patel Sanj KCHAIRMAN & CEO92,348IndirectSep 3, 20269
Paolini John F.CHIEF MEDICAL OFFICER69,922Sep 3, 20266
Moat RossCHIEF OPERATING OFFICER16,307Sep 3, 20264
Megna Michael RCHIEF ACCOUNTING OFFICER29,062Sep 3, 20266
Quart Barry DDirector12,745Aug 21, 20267
Levy Richard SDirector22,359Aug 4, 20263
Cole G BradleyDirector7,172Jul 31, 20262
Malkani Dhiraj HCHIEF STRATEGY OFFICER–Jul 6, 20261
Baker JulianDirector2,744,894IndirectJun 2, 20261
Baker FelixDirector2,744,894IndirectJun 2, 20261
Baker Bros. Advisors LPDirector2,744,894IndirectJun 2, 20261
Baker Brothers Life Sciences LPDirector2,744,894IndirectJun 2, 20261
667, L.P.Director2,744,894IndirectJun 2, 20261
Baker Bros. Advisors (GP) LLCDirector2,744,894IndirectJun 2, 20261
Popovits Kimberly JDirector15,345Jun 2, 20261
Malley ThomasDirector15,345Jun 2, 20261
McCain Tracey LDirector15,345Jun 2, 20261
Tessari EbenCHIEF STRATEGY OFFICER23,130Apr 8, 20267
Pano ArianChief Clinical Dev. Officer–Sep 7, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 15, 2025 (view filing)May 132 daysPatel Sanj KCHAIRMAN & CEOSSaleClass A Ordinary Share−2.87K$27.03−$77.6K−2.9%96.7K after10b5-1
May 9, 2025 (view filing)May 7-92 daysPatel Sanj KCHAIRMAN & CEOSSaleClass A Ordinary Share−8.10K$27.04−$218.9K−7.7%96.7K after3 lots10b5-1
May 9, 2025 (view filing)May 72 daysPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Ordinary Share−200$27.00−$5.40K−0.3%57.4K after10b5-1
May 9, 2025 (view filing)May 72 daysMegna Michael RCHIEF ACCOUNTING OFFICERSSaleClass A Ordinary Share−17.6K$26.69−$471.0K−35.2%32.5K after10b5-1
May 5, 2025 (view filing)May 2-53 daysMoat RossCHIEF COMMERCIAL OFFICERSSaleClass A Ordinary Share−10.1K$28.00−$283.4K−51.8%9.41K after2 lots10b5-1
May 1, 2025 (view filing)Apr 29-May 12 daysMoat RossCHIEF COMMERCIAL OFFICERSSaleClass A Ordinary Share−87.3K$25.96−$2.27M−90.3%9.41K after2 lots10b5-1
May 1, 2025 (view filing)Apr 29-May 12 daysRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Ordinary Share−88.4K$26.56−$2.35M−76.6%27.0K after3 lots10b5-1
Apr 23, 2025 (view filing)Apr 212 daysMoat RossCHIEF COMMERCIAL OFFICERSSaleClass A Ordinary Share−18.3K$20.29−$370.5K−66.0%9.41K after10b5-1
Apr 16, 2025 (view filing)Apr 142 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−12.0K$20.48−$245.8K−13.4%77.4K after2 lots10b5-1
Mar 24, 2025 (view filing)Mar 204 daysRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Ordinary Share−15.9K$23.11−$368.5K−40.5%23.4K after10b5-1
Mar 19, 2025 (view filing)Mar 17-192 daysRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Ordinary Share−20.3K$23.10−$469.9K−46.5%23.4K after2 lots10b5-1
Mar 14, 2025 (view filing)Mar 122 daysMegna Michael RCHIEF ACCOUNTING OFFICERSSaleClass A Ordinary Share−9.05K$22.45−$203.2K−25.4%26.5K after10b5-1
Mar 14, 2025 (view filing)Mar 122 daysRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Ordinary Share−36.4K$22.25−$809.3K−61.3%23.0K after10b5-1
Mar 12, 2025 (view filing)Mar 102 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−12.4K$21.06−$261.3K−13.9%76.6K after10b5-1
Feb 12, 2025 (view filing)Feb 102 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−14.0K$19.57−$274.0K−14.6%82.0K after10b5-1
Jan 15, 2025 (view filing)Jan 132 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−14.0K$18.24−$255.4K−13.6%89.0K after2 lots10b5-1
Dec 18, 2024 (view filing)Dec 162 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−23.0K$20.44−$470.5K−19.3%96.0K after10b5-1
Dec 10, 2024 (view filing)Dec 6-94 daysRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Ordinary Share−27.8K$21.34−$594.0K−54.8%23.0K after2 lots10b5-1
Dec 5, 2024 (view filing)Dec 3-52 daysRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Ordinary Share−15.1K$21.37−$323.0K−39.7%23.0K after3 lots10b5-1
Dec 2, 2024 (view filing)Nov 27-295 daysMegna Michael RCHIEF ACCOUNTING OFFICERSSaleClass A Ordinary Share−8.65K$22.45−$194.1K−24.6%26.5K after2 lots10b5-1
Nov 20, 2024 (view filing)Nov 182 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−17.0K$21.04−$357.7K−14.2%103.0K after10b5-1
Nov 8, 2024 (view filing)Nov 62 daysPatel Sanj KCHAIRMAN & CEOSSaleClass A Ordinary Share−89.6K$23.00−$2.06M−53.0%79.6K after10b5-1
Oct 17, 2024 (view filing)Oct 152 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−17.0K$26.87−$456.8K−13.4%110.0K after10b5-1
Sep 25, 2024 (view filing)Sep 232 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−17.5K$24.99−$437.3K−13.0%117.0K after10b5-1
Sep 4, 2024 (view filing)Sep 31 dayPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Ordinary Share−60.7K$26.12−$1.58M−53.8%52.0K after2 lots10b5-1
Sep 4, 2024 (view filing)Sep 31 dayMoat RossCHIEF COMMERCIAL OFFICERSSaleClass A Ordinary Share−68.5K$26.12−$1.79M−75.9%21.7K after2 lots10b5-1
Aug 29, 2024 (view filing)Aug 272 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Ordinary Share−17.5K$26.91−$470.9K−12.7%119.9K after10b5-1
Jul 25, 2024 (view filing)Jul 232 daysPatel Sanj KCHAIRMAN & CEOSSaleClass A Ordinary Share−136.1K$25.65−$3.49M−68.4%63.0K after3 lots10b5-1
Jul 25, 2024 (view filing)Jul 232 daysRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Ordinary Share−24.2K$24.79−$601.1K−55.7%19.3K after10b5-1
Jul 25, 2024 (view filing)Jul 232 daysPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Ordinary Share−22.0K$26.32−$579.0K−31.5%47.8K after4 lots10b5-1
Mar 11, 2024 (view filing)Mar 74 daysPatel Sanj KCHAIRMAN & CEOSSaleClass A Common Share−65.0K$21.02−$1.37M−100.0%0 after10b5-1
Mar 6, 2024 (view filing)Mar 4-62 daysPatel Sanj KCHAIRMAN & CEOSSaleClass A Common Share−18.3K$21.34−$391.1K−22.0%65.0K after3 lots10b5-1
Mar 5, 2024 (view filing)Mar 14 daysTessari EbenCHIEF OPERATING OFFICERSSaleClass A Common Share−1.19K$22.03−$26.2K−1.0%122.8K after10b5-1
Mar 5, 2024 (view filing)Mar 14 daysPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Common Share−18.8K$21.77−$410.2K−29.6%44.9K after10b5-1
Mar 1, 2024 (view filing)Feb 28-Mar 12 daysMegna Michael RCHIEF ACCOUNTING OFFICERSSaleClass A Common Share−14.8K$21.57−$318.9K−45.7%17.6K after2 lots10b5-1
Feb 29, 2024 (view filing)Feb 272 daysPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Common Share−10.2K$21.03−$213.6K−18.4%44.9K after10b5-1
Jan 4, 2024 (view filing)Jan 31 dayRagosa MarkCHIEF FINANCIAL OFFICERSSaleClass A Common Share−12.0K$20.00−$240.0K−43.4%15.6K after10b5-1
Jan 4, 2024 (view filing)Jan 22 daysMegna Michael RCHIEF ACCOUNTING OFFICERSSaleClass A Common Share−16.7K$19.17−$319.6K−49.5%17.0K after10b5-1
Dec 21, 2023 (view filing)Dec 192 daysMegna Michael RCHIEF ACCOUNTING OFFICERSSaleClass A Common Share−9.32K$19.13−$178.2K−35.4%17.0K after10b5-1
Dec 11, 2023 (view filing)Dec 74 daysPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Common Share−28.6K$17.65−$504.8K−38.9%44.9K after4 lots10b5-1
Sep 6, 2023 (view filing)Sep 51 dayPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Common Share−400$17.53−$7.01K−0.9%44.9K after10b5-1
Jul 27, 2023 (view filing)Jul 252 daysPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Common Share−29.0K$19.14−$555.2K−40.9%41.9K after3 lots
Dec 1, 2022 (view filing)Nov 292 daysQuart Barry DDirectorSSaleClass A Common Share−22.0K$16.15−$354.6K−100.0%0 after
Nov 9, 2022 (view filing)Nov 72 daysPaolini John F.CHIEF MEDICAL OFFICERSSaleClass A Common Share−28.4K$15.18−$430.5K−43.8%36.3K after